Nobody dares stopping clinical research, not even COVID-19

In the global health emergency caused by the COVID-19, clinical trial management has proven to be critical for the pharmaceutical industry, sponsors, and healthcare professionals. Our experience as a sponsor managing interventional oncology clinical studies has provided us with some data and insight...

Descripción completa

Detalles Bibliográficos
Autores principales: Malfettone, Andrea, Di Cosimo, Serena, Pérez-García, José Manuel, García, Alicia, Sampayo-Cordero, Miguel, Mina, Leonardo, Herrero, Carolina, Llombart-Cussac, Antonio, Cortés, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032688/
https://www.ncbi.nlm.nih.gov/pubmed/33833237
http://dx.doi.org/10.1038/s41523-021-00249-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032688/
https://www.ncbi.nlm.nih.gov/pubmed/33833237
http://dx.doi.org/10.1038/s41523-021-00249-1

Ejemplares similares